Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study
Nicole M. Kuderer, Toni K. Choueiri, Dimpy P. Shah, et al.
The Lancet (2020) Vol. 395, Iss. 10241, pp. 1907-1918
Open Access | Times Cited: 1698

Showing 1-25 of 1698 citing articles:

Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life Years for 29 Cancer Groups From 2010 to 2019
Jonathan Kocarnik, Kelly Compton, Frances Dean, et al.
JAMA Oncology (2021) Vol. 8, Iss. 3, pp. 420-420
Open Access | Times Cited: 1242
Systemic immunity in cancer
Kamir J. Hiam-Galvez, Breanna M. Allen, Matthew H. Spitzer
Nature reviews. Cancer (2021) Vol. 21, Iss. 6, pp. 345-359
Open Access | Times Cited: 941
Predictors of COVID‐19 severity: A literature review
Benjamin Gallo Marin, Ghazal Aghagoli, Katya Lavine, et al.
Reviews in Medical Virology (2020) Vol. 31, Iss. 1, pp. 1-10
Open Access | Times Cited: 748
Mortality-related risk factors of COVID-19: a systematic review and meta-analysis of 42 studies and 423,117 patients
Zelalem G. Dessie, Temesgen Zewotir
BMC Infectious Diseases (2021) Vol. 21, Iss. 1
Open Access | Times Cited: 724
Determinants of COVID-19 disease severity in patients with cancer
Elizabeth Robilotti, N. Esther Babady, Peter A. Mead, et al.
Nature Medicine (2020) Vol. 26, Iss. 8, pp. 1218-1223
Open Access | Times Cited: 593
Outcomes of patients with hematologic malignancies and COVID-19: a systematic review and meta-analysis of 3377 patients
Abi Vijenthira, Inna Y. Gong, Thomas A. Fox, et al.
Blood (2020) Vol. 136, Iss. 25, pp. 2881-2892
Open Access | Times Cited: 584
COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study
Lennard Y. W. Lee, Jean‐Baptiste Cazier, Thomas Starkey, et al.
The Lancet Oncology (2020) Vol. 21, Iss. 10, pp. 1309-1316
Open Access | Times Cited: 568
Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study
Francesco Passamonti, Chiara Cattaneo, Luca Arcaini, et al.
The Lancet Haematology (2020) Vol. 7, Iss. 10, pp. e737-e745
Open Access | Times Cited: 522
COVID-19 in Immunocompromised Hosts: What We Know So Far
Monica Fung, Jennifer M. Babik
Clinical Infectious Diseases (2020) Vol. 72, Iss. 2, pp. 340-350
Open Access | Times Cited: 506
Mental health and health behaviours before and during the initial phase of the COVID-19 lockdown: longitudinal analyses of the UK Household Longitudinal Study
Claire L. Niedzwiedz, Michael J. Green, Michaela Benzeval, et al.
Journal of Epidemiology & Community Health (2020) Vol. 75, Iss. 3, pp. 224-231
Open Access | Times Cited: 486
CD8+ T cells contribute to survival in patients with COVID-19 and hematologic cancer
Erin Bange, Nicholas Han, Paul Wileyto, et al.
Nature Medicine (2021) Vol. 27, Iss. 7, pp. 1280-1289
Open Access | Times Cited: 444
The effect of smoking on COVID‐19 severity: A systematic review and meta‐analysis
Rohin K. Reddy, Walton N. Charles, Alexandros Sklavounos, et al.
Journal of Medical Virology (2020) Vol. 93, Iss. 2, pp. 1045-1056
Open Access | Times Cited: 436
Characteristics and predictors of death among 4035 consecutively hospitalized patients with COVID-19 in Spain
Juan Berenguer, Pablo Ryan, Jesús Rodríguez‐Baño, et al.
Clinical Microbiology and Infection (2020) Vol. 26, Iss. 11, pp. 1525-1536
Open Access | Times Cited: 397
Analyses of Risk, Racial Disparity, and Outcomes Among US Patients With Cancer and COVID-19 Infection
QuanQiu Wang, Nathan A. Berger, Rong Xu
JAMA Oncology (2020) Vol. 7, Iss. 2, pp. 220-220
Open Access | Times Cited: 365
Risk Factors for Hospitalization, Mechanical Ventilation, or Death Among 10 131 US Veterans With SARS-CoV-2 Infection
George N. Ioannou, Emily R. Locke, Pamela Green, et al.
JAMA Network Open (2020) Vol. 3, Iss. 9, pp. e2022310-e2022310
Open Access | Times Cited: 364
The association of smoking status with SARS‐CoV‐2 infection, hospitalization and mortality from COVID‐19: a living rapid evidence review with Bayesian meta‐analyses (version 7)
David Simons, Lion Shahab, Jamie Brown, et al.
Addiction (2020) Vol. 116, Iss. 6, pp. 1319-1368
Open Access | Times Cited: 361
Seroconversion rates following COVID-19 vaccination among patients with cancer
Astha Thakkar, Jesus D. Gonzalez‐Lugo, Niyati Goradia, et al.
Cancer Cell (2021) Vol. 39, Iss. 8, pp. 1081-1090.e2
Open Access | Times Cited: 341
Clinical characteristics and outcomes of COVID-19 in haematopoietic stem-cell transplantation recipients: an observational cohort study
Akshay Sharma, Neel S. Bhatt, Andrew St. Martin, et al.
The Lancet Haematology (2021) Vol. 8, Iss. 3, pp. e185-e193
Open Access | Times Cited: 335
Mortality in patients with cancer and coronavirus disease 2019: A systematic review and pooled analysis of 52 studies
Kamal S. Saini, Marco Tagliamento, Matteo Lambertini, et al.
European Journal of Cancer (2020) Vol. 139, pp. 43-50
Open Access | Times Cited: 318
Effect of hydroxychloroquine with or without azithromycin on the mortality of coronavirus disease 2019 (COVID-19) patients: a systematic review and meta-analysis
Thibault Fiolet, Anthony Guihur, Mathieu E. Rebeaud, et al.
Clinical Microbiology and Infection (2020) Vol. 27, Iss. 1, pp. 19-27
Open Access | Times Cited: 295
Association of clinical factors and recent anticancer therapy with COVID-19 severity among patients with cancer: a report from the COVID-19 and Cancer Consortium
Petros Grivas, Ali Raza Khaki, Trisha M. Wise‐Draper, et al.
Annals of Oncology (2021) Vol. 32, Iss. 6, pp. 787-800
Open Access | Times Cited: 294
Outcomes of COVID-19 in patients with CLL: a multicenter international experience
Anthony R. Mato, Lindsey E. Roeker, Nicole Lamanna, et al.
Blood (2020) Vol. 136, Iss. 10, pp. 1134-1143
Open Access | Times Cited: 291
Effects of the COVID-19 Pandemic on Cancer-Related Patient Encounters
Jack London, Elnara Fazio‐Eynullayeva, Matvey B. Palchuk, et al.
JCO Clinical Cancer Informatics (2020), Iss. 4, pp. 657-665
Open Access | Times Cited: 291
Managing cancer patients during the COVID-19 pandemic: an ESMO multidisciplinary expert consensus
Giuseppe Curigliano, Susana Banerjee, Andrés Cervantes, et al.
Annals of Oncology (2020) Vol. 31, Iss. 10, pp. 1320-1335
Open Access | Times Cited: 288
Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer deaths and a population-based cohort study
Alvina G. Lai, Laura Pasea, Amitava Banerjee, et al.
BMJ Open (2020) Vol. 10, Iss. 11, pp. e043828-e043828
Open Access | Times Cited: 277
Page 1 - Next Page

Scroll to top